Related Experiment Video

Updated: May 25, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Accelerated atherosclerosis in patients with SLE--mechanisms and management

Brian J Skaggs1, Bevra H Hahn, Maureen McMahon

  • 1Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, 32-59 Rehab Center, 1000 Veteran Avenue, Los Angeles, CA 90095, USA. bskaggs@mednet.ucla.edu

Nature Reviews. Rheumatology
|February 15, 2012
PubMed

Insights

Systemic lupus erythematosus (SLE) patients face accelerated atherosclerosis due to autoimmunity, not just traditional risk factors. Understanding immune dysfunction is key to managing cardiovascular disease (CVD) risk in these individuals.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) is associated with a significantly higher incidence and earlier onset of cardiovascular disease (CVD) compared to the general population.
  • Traditional CVD risk factors do not fully account for the elevated risk in SLE patients, indicating a role for autoimmunity.
  • Immune system dysfunction is a primary driver of atherosclerosis initiation and progression in SLE.

Purpose of the Study:

  • To review the epidemiology of CVD in SLE.
  • To explore the impact of immune system dysfunction on atherosclerosis development and progression in SLE.
  • To discuss the implications for monitoring and treatment of atherosclerosis in SLE patients.

Main Methods:

  • Literature review and synthesis of existing research on CVD in SLE.
  • Analysis of the role of various autoimmune manifestations (cytokines, autoantibodies, oxidative stress) in atherosclerosis.
  • Discussion of the influence of SLE therapeutics on cardiovascular risk.

Main Results:

  • Autoimmunity, through mechanisms like altered cytokines, autoantibodies, and oxidative stress, significantly contributes to accelerated atherosclerosis in SLE.
  • Both SLE and its treatments can influence the development and progression of atherosclerosis.
  • There is a need for SLE-specific cardiovascular risk factors and biomarker panels.

Conclusions:

  • Immune system dysfunction is central to accelerated atherosclerosis in SLE patients.
  • Developing comprehensive biomarker panels is crucial for identifying and managing high-risk individuals.
  • Further research into SLE-specific CVD risk factors and targeted therapies is warranted.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Inflammation01:38

Inflammation

Overview